TuHURA Biosciences
HURA
8 hedge funds and large institutions have $391K invested in TuHURA Biosciences in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
11% less funds holding
Funds holding: 9 → 8 (-1)
43% less capital invested
Capital invested by funds: $682K → $391K (-$291K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$20.4K |
| 2 |
Barclays
London,
United Kingdom
|
+$6.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$360K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$100K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.79K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $243K | -$360K | -53 | -65% |
|
|
VF
2
Virtu Financial
New York
| $48K | +$20.4K | +3 | +100% |
|
|
3
Barclays
London,
United Kingdom
| $35K | +$6.79K | +1 | +33% |
|
4
Citadel Advisors
Miami,
Florida
| $22K | – | – | – |
|
|
LTFS
5
Ladenburg Thalmann Financial Services
Miami,
Florida
| $20K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $6K | -$6.79K | -1 | -50% |
|
7
Jane Street
New York
| $6K | – | – | – |
|
|
RJFSA
8
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $6K | – | – | – |
|
9
Bank of Montreal
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
TFS
10
TrustCore Financial Services
Brentwood,
Tennessee
| $2K | – | – | – |
|
11
Morgan Stanley
New York
| $1K | – | – | – |
|
|
12
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$100K | -17 | Closed |
|
HURA Hedge Fund Activity: Q1 2019 in Review
8 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2019, worth a combined $391K — down 43% from $682K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HURA and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, adding an estimated $20.4K. The largest seller was Sabby Management, cutting an estimated $360K.
- 8 institutional investors held TuHURA Biosciences (HURA) as of Q1 2019, down from 9 in Q4 2018.
- Funds reported $391K of TuHURA Biosciences stock for Q1 2019, down 43% quarter-over-quarter.
- 0 funds opened new TuHURA Biosciences positions in Q1 2019 and 1 closed out, a net change of -1 holder.
- The largest TuHURA Biosciences buyer in Q1 2019 was Virtu Financial, an estimated $20.4K added.
- The largest TuHURA Biosciences seller in Q1 2019 was Sabby Management, an estimated $360K sold.
Based on aggregated 13F filings for Q1 2019.